Merz Aesthetics announced the launch of Ultherapy Prime—a noninvasive, FDA-cleared medical aesthetics treatment that provides a truly personalized and long-lasting lift of the skin in one session with zero downtime. The Ultherapy Prime platform is the evolution of Ultherapy, which has been recognized as the Gold Standard for nonsurgical skin lifting due to its large body of clinical evidence, well-established mechanism of action (MOA) and high patient satisfaction. Ultherapy Prime redefines the future of nonsurgical skin lifting by combining advanced ultrasound technology, vivid real-time imaging, and proven results. These advancements promote long-lasting results paired with healthier-looking skin.
The platform's modern design and advanced operating system deliver 20 percent faster treatments, elevated ergonomics, and more efficient workflows for aesthetic health care professionals. Ultherapy Prime's 35 percent larger screen and faster image refresh rate provide brighter, crisper images from all angles, ensuring a vivid visualization experience. “The launch of Ultherapy Prime demonstrates our commitment to persist in innovation,” says Bob Rhatigan, CEO, Merz Aesthetics. “As the leader in noninvasive lifting, we’re excited to bring Ultherapy Prime to our customers as the next generation, premier platform and as a proven technology and customizable, long-lasting treatment option.”
Ultherapy Prime’s unique technology with real-time visualization goes beyond other noninvasive treatments to target the right collagen and elastin-rich layers of the tissue at multiple depths, delivering consistent and precise energy where the patient needs it the most. Ultherapy Prime’s mechanism of action allows for personalized skin lifting outcomes through collagen and elastin stimulation, which can last up to a year or more. It is a great treatment option for all skin types and skin tones to maintain a youthful, healthy appearance in just one session with zero downtime.